US Stock MarketDetailed Quotes

4D Molecular Therapeutics (FDMT)

Watchlist
  • 7.610
  • -1.150-13.13%
Close Jan 15 16:00 ET
  • 7.610
  • 0.0000.00%
Post 20:01 ET
434.80MMarket Cap-2.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

4D Molecular Therapeutics (FDMT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
2,900.00%90K
200.00%15K
-50.00%14K
-99.82%37K
105.26%1K
-99.99%3K
-97.91%5K
-90.60%28K
562.29%20.72M
-101.52%-19K
Operating revenue
2,900.00%90K
200.00%15K
-50.00%14K
-99.82%37K
105.26%1K
-99.99%3K
-97.91%5K
-90.60%28K
562.29%20.72M
-101.52%-19K
Cost of revenue
Gross profit
Operating expense
19.83%61.28M
40.06%59.47M
40.54%53.64M
40.64%187.88M
53.19%56.12M
49.61%51.14M
31.15%42.46M
25.52%38.16M
18.05%133.59M
22.24%36.63M
Selling and administrative expenses
-6.43%11.84M
8.67%11.52M
25.67%12.94M
27.63%46.58M
22.88%13.03M
38.84%12.65M
20.59%10.6M
28.80%10.29M
10.90%36.49M
25.25%10.61M
-General and administrative expense
-6.43%11.84M
8.67%11.52M
25.67%12.94M
27.63%46.58M
22.88%13.03M
38.84%12.65M
20.59%10.6M
28.80%10.29M
10.90%36.49M
25.25%10.61M
Research and development costs
28.46%49.44M
50.51%47.95M
46.03%40.7M
45.53%141.3M
65.54%43.09M
53.53%38.48M
35.09%31.86M
24.35%27.87M
20.99%97.1M
21.06%26.03M
Operating profit
-19.66%-61.19M
-40.04%-59.46M
-40.60%-53.62M
-66.43%-187.84M
-53.11%-56.12M
-265.91%-51.13M
-32.11%-42.46M
-26.67%-38.14M
-2.58%-112.87M
-27.62%-36.65M
Net non-operating interest income expense
-40.60%4.33M
-35.63%4.86M
-2.84%5.58M
121.52%27.05M
47.65%6.47M
88.08%7.29M
200.48%7.55M
298.13%5.75M
374.58%12.21M
227.35%4.38M
Non-operating interest income
-40.60%4.33M
-35.63%4.86M
-2.84%5.58M
121.52%27.05M
47.65%6.47M
88.08%7.29M
200.48%7.55M
298.13%5.75M
374.58%12.21M
227.35%4.38M
Other net income (expense)
-2,000.00%-21K
-35.56%-61K
770.00%67K
57.46%-77K
-90.91%-21K
99.37%-1K
-662.50%-45K
47.37%-10K
-417.14%-181K
-466.67%-11K
Other non- operating income (expenses)
-2,000.00%-21K
-35.56%-61K
770.00%67K
57.46%-77K
-90.91%-21K
99.37%-1K
-662.50%-45K
47.37%-10K
-417.14%-181K
-466.67%-11K
Income before tax
-29.73%-56.88M
-56.38%-54.66M
-48.06%-47.97M
-59.53%-160.87M
-53.86%-49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
Income tax
Net income
-29.73%-56.88M
-56.38%-54.66M
-48.06%-47.97M
-59.53%-160.87M
-53.86%-49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
Net income continuous Operations
-29.73%-56.88M
-56.38%-54.66M
-48.06%-47.97M
-59.53%-160.87M
-53.86%-49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
Minority interest income
Net income attributable to the parent company
-29.73%-56.88M
-56.38%-54.66M
-48.06%-47.97M
-59.53%-160.87M
-53.86%-49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-29.73%-56.88M
-56.38%-54.66M
-48.06%-47.97M
-59.53%-160.87M
-53.86%-49.67M
-327.49%-43.84M
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
Basic earnings per share
-27.85%-1.01
-55.56%-0.98
-30.30%-0.86
-15.50%-2.98
-16.88%-0.9
-229.17%-0.79
18.18%-0.63
25.00%-0.66
22.29%-2.58
8.33%-0.77
Diluted earnings per share
-27.85%-1.01
-55.56%-0.98
-30.30%-0.86
-15.50%-2.98
-16.88%-0.9
-229.17%-0.79
18.18%-0.63
25.00%-0.66
22.29%-2.58
8.33%-0.77
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 2,900.00%90K200.00%15K-50.00%14K-99.82%37K105.26%1K-99.99%3K-97.91%5K-90.60%28K562.29%20.72M-101.52%-19K
Operating revenue 2,900.00%90K200.00%15K-50.00%14K-99.82%37K105.26%1K-99.99%3K-97.91%5K-90.60%28K562.29%20.72M-101.52%-19K
Cost of revenue
Gross profit
Operating expense 19.83%61.28M40.06%59.47M40.54%53.64M40.64%187.88M53.19%56.12M49.61%51.14M31.15%42.46M25.52%38.16M18.05%133.59M22.24%36.63M
Selling and administrative expenses -6.43%11.84M8.67%11.52M25.67%12.94M27.63%46.58M22.88%13.03M38.84%12.65M20.59%10.6M28.80%10.29M10.90%36.49M25.25%10.61M
-General and administrative expense -6.43%11.84M8.67%11.52M25.67%12.94M27.63%46.58M22.88%13.03M38.84%12.65M20.59%10.6M28.80%10.29M10.90%36.49M25.25%10.61M
Research and development costs 28.46%49.44M50.51%47.95M46.03%40.7M45.53%141.3M65.54%43.09M53.53%38.48M35.09%31.86M24.35%27.87M20.99%97.1M21.06%26.03M
Operating profit -19.66%-61.19M-40.04%-59.46M-40.60%-53.62M-66.43%-187.84M-53.11%-56.12M-265.91%-51.13M-32.11%-42.46M-26.67%-38.14M-2.58%-112.87M-27.62%-36.65M
Net non-operating interest income expense -40.60%4.33M-35.63%4.86M-2.84%5.58M121.52%27.05M47.65%6.47M88.08%7.29M200.48%7.55M298.13%5.75M374.58%12.21M227.35%4.38M
Non-operating interest income -40.60%4.33M-35.63%4.86M-2.84%5.58M121.52%27.05M47.65%6.47M88.08%7.29M200.48%7.55M298.13%5.75M374.58%12.21M227.35%4.38M
Other net income (expense) -2,000.00%-21K-35.56%-61K770.00%67K57.46%-77K-90.91%-21K99.37%-1K-662.50%-45K47.37%-10K-417.14%-181K-466.67%-11K
Other non- operating income (expenses) -2,000.00%-21K-35.56%-61K770.00%67K57.46%-77K-90.91%-21K99.37%-1K-662.50%-45K47.37%-10K-417.14%-181K-466.67%-11K
Income before tax -29.73%-56.88M-56.38%-54.66M-48.06%-47.97M-59.53%-160.87M-53.86%-49.67M-327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M
Income tax
Net income -29.73%-56.88M-56.38%-54.66M-48.06%-47.97M-59.53%-160.87M-53.86%-49.67M-327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M
Net income continuous Operations -29.73%-56.88M-56.38%-54.66M-48.06%-47.97M-59.53%-160.87M-53.86%-49.67M-327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M
Minority interest income
Net income attributable to the parent company -29.73%-56.88M-56.38%-54.66M-48.06%-47.97M-59.53%-160.87M-53.86%-49.67M-327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -29.73%-56.88M-56.38%-54.66M-48.06%-47.97M-59.53%-160.87M-53.86%-49.67M-327.49%-43.84M-18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M
Basic earnings per share -27.85%-1.01-55.56%-0.98-30.30%-0.86-15.50%-2.98-16.88%-0.9-229.17%-0.7918.18%-0.6325.00%-0.6622.29%-2.588.33%-0.77
Diluted earnings per share -27.85%-1.01-55.56%-0.98-30.30%-0.86-15.50%-2.98-16.88%-0.9-229.17%-0.7918.18%-0.6325.00%-0.6622.29%-2.588.33%-0.77
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -